Antigen binding and stability properties of non-covalently linked anti-CD22 single-chain Fv dimers

被引:21
作者
Arndt, MAE
Krauss, R
Rybak, SM
机构
[1] Univ Hosp Essen, Inst Immunol, D-45122 Essen, Germany
[2] NCI, SAIC, Frederick, MD 21702 USA
[3] NCI, Dev Therapeut Program, Frederick, MD 21702 USA
关键词
CD22; single chain Fv; diabody; dimer; stability;
D O I
10.1016/j.febslet.2004.11.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
By varying linker length and domain orientation three multivalent derivatives of a monovalent anti-CD22 single-chain fragment variable (scFv) antibody were generated. Shortening the linker of the V-H-V-L oriented scFv to 5 or 0 residues resulted in the formation of diabodies or a mixture of tetramers and trimers, respectively. Unexpectedly, a V-L-0-V-H scFv assembled to homogenous dimers, remained substantially more stable than the V-H-5-V-L diabody when incubated in human serum at 37 degreesC, and retained its dimeric state when concentrated up to 4 mg/ml. These properties suggest the V-L-0-V-H scFv could become an attractive vehicle for the selective delivery of multiple effector molecules to CD22(+) tumor cells. (C) 2004 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:257 / 261
页数:5
相关论文
共 32 条
[11]   PROTEIN ENGINEERING OF ANTIBODY-BINDING SITES - RECOVERY OF SPECIFIC ACTIVITY IN AN ANTI-DIGOXIN SINGLE-CHAIN FV ANALOG PRODUCED IN ESCHERICHIA-COLI [J].
HUSTON, JS ;
LEVINSON, D ;
MUDGETTHUNTER, M ;
TAI, MS ;
NOVOTNY, J ;
MARGOLIES, MN ;
RIDGE, RJ ;
BRUCCOLERI, RE ;
HABER, E ;
CREA, R ;
OPPERMANN, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (16) :5879-5883
[12]   Triabodies: Single chain Fv fragments without a linker form trivalent trimers [J].
Iliades, P ;
Kortt, AA ;
Hudson, PJ .
FEBS LETTERS, 1997, 409 (03) :437-441
[13]   Single-chain Fv fragments of anti-neuraminidase antibody NC10 containing five- and ten-residue linkers form dimers and with zero-residue linker a trimer [J].
Kortt, AA ;
Lah, M ;
Oddie, GW ;
Gruen, CL ;
Burns, JE ;
Pearce, LA ;
Atwell, JL ;
McCoy, AJ ;
Howlett, GJ ;
Metzger, DW ;
Webster, RG ;
Hudson, PJ .
PROTEIN ENGINEERING, 1997, 10 (04) :423-433
[14]   Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia [J].
Kreitman, RJ ;
Wilson, WH ;
Bergeron, K ;
Raggio, M ;
Stetler-Stevenson, M ;
FitzGerald, DJ ;
Pastan, I .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (04) :241-247
[15]   Immunosuppressive properties of anti-CD3 single-chain Fv and diabody [J].
Le Gall, F ;
Reusch, U ;
Moldenhauer, G ;
Little, M ;
Kipriyanov, SM .
JOURNAL OF IMMUNOLOGICAL METHODS, 2004, 285 (01) :111-127
[16]   Di-, tri- and tetrameric single chain Fv antibody fragments against human CD19: effect of valency on cell binding [J].
Le Gall, F ;
Kipriyanov, SM ;
Moldenhauer, G ;
Little, M .
FEBS LETTERS, 1999, 453 (1-2) :164-168
[17]   Reversible dimer formation and stability of the anti-tumour single-chain Fv antibody MFE-23 by neutron scattering, analytical ultracentrifugation, and NMR and FT-IR spectroscopy [J].
Lee, YC ;
Boehm, MK ;
Chester, KA ;
Begent, RHJ ;
Perkins, SJ .
JOURNAL OF MOLECULAR BIOLOGY, 2002, 320 (01) :107-127
[18]   CHIMERIZATION OF LL2, A RAPIDLY INTERNALIZING ANTIBODY SPECIFIC FOR B-CELL LYMPHOMA [J].
LEUNG, SO ;
SHEVITZ, J ;
PELLEGRINI, MC ;
DION, AS ;
SHIH, LB ;
GOLDENBERG, DM ;
HANSEN, HJ .
HYBRIDOMA, 1994, 13 (06) :469-476
[19]   RECOMBINANT ANTINEURAMINIDASE SINGLE-CHAIN ANTIBODY - EXPRESSION, CHARACTERIZATION, AND CRYSTALLIZATION IN COMPLEX WITH ANTIGEN [J].
MALBY, RL ;
CALDWELL, JB ;
GRUEN, LC ;
HARLEY, VR ;
IVANCIC, N ;
KORTT, AA ;
LILLEY, GG ;
POWER, BE ;
WEBSTER, RG ;
COLMAN, PM ;
HUDSON, PJ .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 1993, 16 (01) :57-63
[20]  
Mayer A, 2000, CLIN CANCER RES, V6, P1711